A Phase 1 clinical trial of an experimental vaccine designed to provide protection against mosquito-borne diseases such as malaria, Zika and dengue will involve up to 60 adult participants. How does this AGS-v vaccine work?
Clinical Trial To Test Mosquito Saliva Vaccine For Malaria, Zika And Dengue Viruses
Tech Times - 22 Feb 2017 16:07
A Phase 1 clinical trial of an experimental vaccine designed to provide protection against mosquito-borne diseases such as malaria, Zika and dengue will involve up to 60 adult participants. How does this AGS-v vaccine work?
Share this Article
Recommended